Copyright
©The Author(s) 2024.
World J Gastroenterol. Feb 14, 2024; 30(6): 579-598
Published online Feb 14, 2024. doi: 10.3748/wjg.v30.i6.579
Published online Feb 14, 2024. doi: 10.3748/wjg.v30.i6.579
Ref. | Country | Design | Population, n | Prevalence (%) | Reference standard | Index test (model) | Optimal cut-off | Urea dosing (mg) | Time after administration (min) | Measurement tecnique | TP | FP | TN | FN |
Wang et al[29], 2021 | China | Cross-sectional | 217 | 65.9 | HE | 13C-UBT | 10.4‰ DOB | 50 | 30 | IS | 120 | 14 | 60 | 23 |
Alzoubi et al[33], 2020 | Jordan | Cross-sectional | 30 | 56.7 | RUT or HE | 13C-UBT | 4‰ DOB | 75 | 30 | IS | 16 | 3 | 10 | 1 |
Nawacki et al[34], 2018 | Poland | Cross-sectional | 50 | 36.0 | RUT | 13C-UBT | 9.5‰ DOB | NR | 30 | IS | 16 | 0 | 32 | 2 |
Som et al[27], 2014 | India | Cross-sectional | 83 | 59.0 | RUT | 13C-UBT | 1.47‰ | 75 | Multiple times | ICOS | 49 | 0 | 34 | 0 |
Bruden et al[35], 2011 | United States | Cross-sectional | 280 | 53.2 | HE or (HpC and RUT) | 13C-UBT | 7 DOB | NR | NR | NR | 139 | 16 | 115 | 10 |
Peng et al [36], 2009 | Taiwan | Cross-sectional | 100 | 53.0 | HpC or (HE and RUT) | 13C-UBT | 4.8‰ DOB | 100 | 15 | IS | 53 | 7 | 40 | 0 |
Jordaan et al[37], 2008 | South Africa | Cross-sectional | 103 | 58.3 | HE | 13C-UBT | 4.5‰ DOB | 75 | NR | GCMS | 55 | 3 | 40 | 5 |
Gatta et al[26], 2006 | Italy | RCT | 100 | 43.0 | HE and RUT | 13C-UBT | 4.40‰-6.26‰ DOB | 25 | 30 | IRMS | 43 | 0 | 57 | 0 |
Peng et al[38], 2005 | Taiwan | Cross-sectional | 50 | 36.0 | HpC or (HE and RUT) | 13C-UBT | 5‰ DOB | 100 | 15 | IRMS | 18 | 0 | 32 | 0 |
Kato et al[39], 2004 | Japan | Cross-sectional | 254 | 51.1 | HpC or (HE and RUT) | 13C-UBT | 2.5‰ DOB | 100 | 20 | IRMS | 252 | 5 | 242 | 6 |
Ohara et al[40], 2004 | Japan | Cross-sectional | 254 | 51.2 | HpC or (HE and RUT) | 13C-UBT | 2.5‰ DOB | 100 | Multiple times | IRMS | 127 | 2 | 122 | 3 |
Chen et al[41], 2003 | Taiwan | Cross-sectional | 554 | 66.6 | HpC or (HE and RUT) | 13C-UBT | 3.5‰ DOB | 100 | 20 | IS | 361 | 6 | 179 | 8 |
Valdepérez et al[42], 2003 | Spain | Cross-sectional | 85 | 76.8 | HE and RUT | 13C-UBT | NR | 100 | 30 | NR | 61 | 0 | 19 | 2 |
Gatta et al[43], 2003 | Italy | Cross-sectional | 200 | 56.5 | HpC or (HE and RUT) | 13C-UBT | 3.11‰-6.84‰ DOB | 75 | 30 | IRMS | 113 | 0 | 87 | 0 |
Wong et al[44], 2003 | China | Cross-sectional | 200 | 49.5 | HE and RUT | 13C-UBT | 2.1‰ DOB | 50 | 20 | IRMS | 99 | 0 | 101 | 0 |
Ng et al[45], 2002 | China | Cross-sectional | 213 | 54.9 | HE and RUT | 13C-UBT | 4.0‰-6.5‰ DOB | 75 | 30 | IRMS | 112 | 2 | 94 | 5 |
Wong et al[46], 2001 | China | Cross-sectional | 101 | 48.1 | HE and RUT | 13C-UBT | 7.0-8.0‰ DOB | 50 | 20 | IRMS | 99 | 4 | 103 | 0 |
Wong et al[47], 2001 | China | Cross-sectional | 294 | 55.4 | HE, HpC, CLO (RUT), in-house RUT, PCR, UBT (at least four positive) | 13C-UBT | 5‰ DOB | 75 | 30 | IRMS | 151 | 4 | 127 | 12 |
Shirin et al[48], 2001 | United States | Cross-sectional | 97 | 47.4 | HE and RUT | 13C-UBT | Positive: > 6‰ DOB (> 2 points)/negative: < 3‰ DOB (> 2 points) | 75 | 5 | MCS | 45 | 2 | 49 | 1 |
Pilotto et al[49], 2000 | Italy | Cross-sectional | 96 | 51.0 | HE, HpC, and RUT | 13C-UBT | 5‰ DOB | 100 | 30 | IRMS | 49 | 2 | 45 | 0 |
Sheu et al[50], 2000 | Taiwan | Cross-sectional | 177 | 47.5 | HE or HpC | 13C-UBT | 3.5 DOB | 50 | 15 | IS | 81 | 1 | 92 | 3 |
Wong et al[51], 2000 | China | Cross-sectional | 202 | 56.4 | HE and RUT | 13C-UBT | 4.5‰ DOB | 75 | 30 | IRMS | 108 | 2 | 86 | 6 |
Hahn et al[52], 2000 | United States | Cross-sectional | 67 | 6.0 | HE and at least two positives of (definitive presence of H. pylori organisms in HE, UBT, Serology) | 13C-UBT | 2.4‰ DOB | 125 | 30 | IRMS | 4 | 9 | 54 | 0 |
Chen et al[53], 2000 | Japan | Cross-sectional | 162 | 83.3 | HE and Serology | 13C-UBT | 2.5‰ DOB | 100 | 20 | IRMS | 135 | 1 | 26 | 0 |
Peng et al[54], 2000 | Taiwan | Cross-sectional | 136 | 59.6 | HpC or (HE and RUT) | 13C-UBT | 4.8‰ DOB | 100 | 15 | IRMS | 76 | 6 | 49 | 5 |
Riepl et al[55], 2000 | Germany | Cross-sectional | 84 | 35.7 | HE, HpC, and RUT | 13C-UBT | 6.5‰ DOB | 75 | 15 | IS | 30 | 0 | 54 | 0 |
D'Elios et al[56], 2000 | Italy | Cross-sectional | 256 | 45.3 | HE | 13C-UBT | 4‰ DOB | 75 | 30 | IRMS | 113 | 2 | 138 | 3 |
van der Hulst et al[57], 1999 | Italy | Cross-sectional | 544 | 52.2 | HE or HpC | 13C-UBT | 7.5‰ DOB ± 0.8 | 100 | 30 | LOGES | 260 | 21 | 239 | 24 |
Leodolter et al[58], 1999 | Germany | Cross-sectional | 320 | 48.1 | HpC or (HE and RUT) | 13C-UBT | 4‰ DOB | 75 | 30 | IRMS | 142 | 2 | 164 | 12 |
Mock et al[59], 1999 | Canada | Cross-sectional | 98 | 19.8 | HE or (RUT and Serology) | 13C-UBT | 3‰ DOB | 75 | 30 | IRMS | 17 | 2 | 75 | 2 |
Mock et al[59], 1999 | Korea | Cross-sectional | 107 | 68.2 | HE or (RUT and Serology) | 13C-UBT | 3‰ DOB | 75 | 30 | IRMS | 69 | 1 | 33 | 4 |
Perri et al[60], 1998 | Belgium | Cross-sectional | 172 | 73.3 | HE or HpC | 13C-UBT | 1.15‰ DOB | 75 | 60 | IRMS | 121 | 1 | 45 | 5 |
Ohara et al[61], 1998 | Japan | Cross-sectional | 213 | 77.5 | HpC or at least two positives of (HE, RUT, Serology) | 13C-UBT | 2.5‰ DOB | 100 | 20 | IRMS | 162 | 1 | 47 | 3 |
Leodolter et al[62], 1998 | Germany | Cross-sectional | 40 | 50.0 | HpC or (HE and RUT) | 13C-UBT | 4‰ DOB | 75 | 10 | IRMS | 20 | 0 | 20 | 0 |
Andersen et al[63], 1998 | Denmark | Cross-sectional | 97 | 54.6 | HE or HpC | 13C-UBT | 5‰ DOB | 100 | Multiple times | IRMS | 46 | 4 | 40 | 7 |
Ellenrieder et al[64], 1997 | Germany | Cross-sectional | 132 | 43.2 | (HE, HpC, RUT) at least two positives | 13C-UBT | 3.5‰ DOB | NR | 30 | IS | 52 | 8 | 67 | 5 |
Epple et al[65], 1997 | Germany | Cross-sectional | 126 | 61.1 | HE | 13C-UBT | 1.3‰ DOB | 75 | 30 | IRMS | 74 | 7 | 42 | 3 |
Labenz et al[66], 1996 | Germany | Cross-sectional | 70 | 67.1 | HE or HpC | 13C-UBT | 4‰ DOB | 75 | 30 | IRMS | 46 | 0 | 23 | 1 |
Logan et al[67], 1991 | England | Cross-sectional | 56 | 68.0 | HE | 13C-UBT | 4.5‰ DOB | 125 | Multiple times | IRMS | 32 | 1 | 15 | 2 |
Dill et al[68], 1990 | Scotland | Cross-sectional | 69 | 49.3 | HpC | 13C-UBT | 3‰ c-PDR | 250 | 20 | IRMS | 33 | 0 | 35 | 1 |
- Citation: Lemos FFB, Castro CT, Silva Luz M, Rocha GR, Correa Santos GL, de Oliveira Silva LG, Calmon MS, Souza CL, Zarpelon-Schutz AC, Teixeira KN, Queiroz DMM, Freire de Melo F. Urea breath test for Helicobacter pylori infection in adult dyspeptic patients: A meta-analysis of diagnostic test accuracy. World J Gastroenterol 2024; 30(6): 579-598
- URL: https://www.wjgnet.com/1007-9327/full/v30/i6/579.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i6.579